A (Agilent Technologies) Debt-to-EBITDA : (As of Jul. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

A Agilent Technologies Inc A
96 GF Score
Price $156.47
GF Value $149.31
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Agilent Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Agilent Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2026 was $304 Mil. Agilent Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2026 was $3,645 Mil. Agilent Technologies's annualized EBITDA for the quarter that ended in Jul. 2026 was $2,156 Mil. Agilent Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2026 was 1.83.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Agilent Technologies's Debt-to-EBITDA or its related term are showing as below:

A' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.45   Med: 1.82   Max: 2.21
Current: 1.94

During the past 13 years, the highest Debt-to-EBITDA Ratio of Agilent Technologies was 2.21. The lowest was 1.45. And the median was 1.82.

A's Debt-to-EBITDA is ranked better than
55.93% of 118 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.475 vs A: 1.94

Agilent Technologies  (NYSE:A) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Agilent Technologies Debt-to-EBITDA Related Terms

Agilent Technologies Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Agilent Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilent Technologies Debt-to-EBITDA Chart

Agilent Technologies Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Agilent Technologies Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

A vs IQV, IDXX, WAT: Debt-to-EBITDA Comparison

For the Diagnostics & Research subindustry, Agilent Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agilent Technologies Debt-to-EBITDA vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Debt-to-EBITDA falls into.


A
96GF Score
Agilent Technologies Inc A
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilent Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Agilent Technologies's Debt-to-EBITDA for the fiscal year that ended in Oct. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(348 + 3195) / 1834
=1.93

Agilent Technologies's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(304 + 3645) / 2156
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jul. 2026) EBITDA data.

Is Agilent Technologies (A) Overvalued in 2026?

Based on GuruFocus' analysis, Agilent Technologies stock appears to be overvalued. The current stock price of $156.47 is trading 4.8% above its estimated GF Value™ of $149.31. GuruFocus considers Agilent Technologies to be Fairly Valued.

Key valuation signals for A:

  • Debt-to-EBITDA:
  • GF Value™: $149.31 vs. price of $156.47 (4.8% above fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilent Technologies Business Description

Address 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
96GF Score

Get the complete analysis for A

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$156.47
Price
$149.31
GF Value